| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8715314 | Journal of the American Academy of Dermatology | 2018 | 35 Pages |
Abstract
This disease-based registry cohort represents a population exposed to multiple therapies, long disease duration, and multiple comorbidities and can be used to examine comparative safety and efficacy of various therapies.
Keywords
TNFNPFEQ-5D-3LVASDLQIEQ-5DPSABSApsoriatic arthritisEffectivenessInvestigator Global AssessmentSafetyIgAinterleukinPASIRegistryBiologic therapyReal-worldbody surface areaSystemic therapybody mass indexBMIPsoriasis Area Severity IndexDermatology Life Quality Indextumor necrosis factorvisual analog scalepatient-reported outcomePROPsoriasis
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
Bruce MD, PhD, Chitra MPH, Marc MS, Ning MS, Stacey H. PharmD, Jeffrey D. MD, MPH, Mark MD,